As part of the occasional Amgen Innovator Series featuring high-profile Bay Area life sciences leaders, Wave 80 founder Dan Laser spoke today at the California Institute for Quantitative Biosciences, (QB3).
Dr. Laser’s broad-ranging talk included discussion of technical topics such principles and applications of lipid nanoparticle technology as well as broader start-up priorities such as the coming MDR regulatory regime in Europe and U.S. reimbursement trends.
Related Posts
